Sign in
CompletedPhase 4

NLR and PLR Levels Following IPACK Block in Knee Arthroplasty

Key facts

Who runs it
Poznan University of Medical Sciences
Where
Poland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 4
People taking part
60 people enrolled
Started
30 Mar 2024
Ended
10 Feb 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • 0.9% Sodium Chloride Injection
  • Ropivacaine 0.2% Injectable Solution
Record updated
24 March 2025

Who can take part

Age
20 years to 90 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Patients with ASA classification I-III
  • Aged 20-90 years
  • Who will be scheduled for hip arthroplasty under spinal anesthesia

Who cannot take part

  • Take anticoagulant therapy
  • Patients who have a history of bleeding diathesis
  • History of chronic pain before surgery
  • patients unable to assess their pain (dementia)
  • patients having an infection in region of the procedure
  • Multiple trauma
  • patients operated under general anesthesia
  • patient who do not accept the procedure

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Effect of iPACK block on NLR and PLR following knee arthroplasty

The 2 groups in the trial

  • Sham blocksExisting treatment, for comparison

    iPACK block with 20ml of 0.9% sodium chloride

    Treatment: 0.9% Sodium Chloride Injection

  • iPACK blockExisting treatment, for comparison

    iPACK block with 20ml 0f 0.2% ropivacaine

    Treatment: Ropivacaine 0.2% Injectable Solution

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Neutrophil-to-lymphocyte Ratio (NLR) and Platelet-to-lymphocyte Ratio (PLR) Levels Following IPACK Block in Knee Arthroplasty: a Randomized, Controlled Trial.
Record updated
24 March 2025